Xylem (NYSE:XYL) Raised to Strong-Buy at Zacks Research

Key Points

• Zacks Research upgraded Xylem from a "hold" rating to a "strong-buy" rating, indicating increased confidence in the stock's performance.
• Recent price targets for Xylem have been raised by multiple analysts, with Stifel Nicolaus increasing its target from $162.00 to $175.00, reflecting a positive outlook for the company.
• Xylem reported strong earnings with an EPS of $1.26 for the last quarter, exceeding analysts' expectations and showing a revenue increase of 6.1% year-over-year.

Xylem (NYSE:XYL - Get Free Report) was upgraded by Zacks Research from a "hold" rating to a "strong-buy" rating in a research report issued on Monday,Zacks.com reports.

A number of other equities research analysts have also recently commented on the stock. Stifel Nicolaus raised their price objective on shares of Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Citigroup reissued a "buy" rating and set a $152.00 price target (up from $137.00) on shares of Xylem in a report on Monday, July 14th. UBS Group lifted their price objective on shares of Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a report on Tuesday, August 5th. Mizuho upped their price objective on shares of Xylem from $125.00 to $140.00 and gave the stock a "neutral" rating in a research report on Friday, September 12th. Finally, Barclays began coverage on Xylem in a research report on Friday, September 19th. They set an "overweight" rating and a $165.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $152.33.

Xylem Stock Performance

NYSE XYL opened at $143.05 on Monday. The stock has a 50-day simple moving average of $139.75 and a two-hundred day simple moving average of $128.23. The firm has a market capitalization of $34.82 billion, a P/E ratio of 37.15, a PEG ratio of 2.48 and a beta of 1.09. Xylem has a fifty-two week low of $100.47 and a fifty-two week high of $145.33. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. The firm had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The company's revenue was up 6.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, equities analysts forecast that Xylem will post 4.65 earnings per share for the current year.

Insider Activity at Xylem

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the transaction, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This trade represents a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.27% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Valley National Advisers Inc. lifted its stake in shares of Xylem by 84.9% in the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock worth $26,000 after buying an additional 101 shares in the last quarter. Perkins Coie Trust Co acquired a new stake in Xylem in the 1st quarter valued at about $27,000. Maseco LLP purchased a new position in Xylem in the 2nd quarter worth approximately $31,000. Center for Financial Planning Inc. boosted its holdings in shares of Xylem by 52.0% during the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock worth $32,000 after purchasing an additional 91 shares during the last quarter. Finally, ST Germain D J Co. Inc. grew its position in shares of Xylem by 950.0% in the second quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company's stock valued at $33,000 after purchasing an additional 228 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.